<DOC>
	<DOCNO>NCT02520362</DOCNO>
	<brief_summary>This prospective open cohort study annual assessment report descriptive finding final report end study address study objective . The study period include 10 year data accumulate data system . The study start date denosumab international birth date , 26 May 2010 . The data end date 10 year international birth date , 25 May 2020.The primary data source follow : • US Medicare , include Parts A , B , D• United HealthCare• Scandinavian national health registry database , include data Denmark , Sweden , Norway . Data collect postmenopausal woman overall , woman Postmenopausal Osteoporosis , patient receive Prolia unapproved indication . Among woman Postmenopausal Osteoporosis , exposure cohort establish base exposure denosumab bisphosphonates . Nine adverse event special interest identify use validate algorithm base inpatient outpatient diagnosis procedure code , , AESI , medication code laboratory data . Selected AESI ( osteonecoris jaw atypical femoral fracture ) confirm medical chart review .</brief_summary>
	<brief_title>Safety Assessment Among Women With Postmenopausal Osteoporosis Men With Osteoporosis Multiple Observational Databases</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion Criteria woman postmenopausal osteoporosis : Postmenopausal woman : Postmenopausal status determine base age define woman ≥ 55 year old . For Medicare database , woman ≥ 65 year old include analysis , give generally individual US ≥ 65 year old eligible Medicare coverage data postmenopausal woman le 65 year old available small number woman meet specialized eligibility criterion . Women Post Menopausal Osteoporosis : The presence Post Menopausal Osteoporosis determine utilize algorithm base upon definition postmenopausal woman ( ≥ 65 year old Medicare ≥ 55 year old data system ) , diagnostic code indicate osteoporosis , diagnostic code indicate osteoporotic fracture , and/or relevant postmenopausal osteoporosis treatment code . Exclusion Criteria woman postmenopausal osteoporosis : • Women postmenopausal osteoporosis : Women Paget 's disease 12month period prior meet criterion inclusion postmenopausal osteoporosis population exclude . Additionally , US Medicare United Healthcare , woman diagnosis malignancy ( exclude nonmelanoma skin cancer ) treatment chemotherapy , hormonal therapy radiation therapy cancer 12months index date exclude . In Scandinavian national registry , woman diagnosis cancer accord patient registry and/or cancer registry 12months prior meeting criterion inclusion postmenopausal osteoporosis population exclude . Inclusion criterion men osteoporosis : Men ≥ 65 year old Medicare database ≥ 30 year old United Healthcare receive least one denosumab 60 mg injection include . All men need continuously enrol least 12 month prior start followup . A diagnosis code osteoporosis osteoporotic fracture would require know male osteoporosis underdiagnosed . The exclusion patient cancer Paget disease ( describe Exclusion Criteria Section ) ensure patient treat Prolia osteoporosis indication . The index date define date patient first satisfies inclusion criterion . Exclusion Criteria men osteporosis : Men diagnosis malignancy ( exclude nonmelanoma skin cancer ) treatment chemotherapy , hormonal therapy radiation therapy cancer 12 month index date exclude . Men Paget 's disease 12month period prior index date also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>